Literature DB >> 2314483

Propranolol inhibits nonexocytotic noradrenaline release in myocardial ischemia.

G Richardt1, U Lumpp, M Haass, A Schömig.   

Abstract

Ischemic induces a nonexocytotic noradrenaline release in the heart, which leads to high and potentially harmful interstitial noradrenaline concentrations. The effect of beta-adrenoceptor antagonists on noradrenaline release in ischemia has been investigated in the present study. DL-Propranolol (1-100 mumol/l) concentration-dependently reduced noradrenaline release during 20 min of global and total ischemia in the perfused rat heart. Other beta-adrenoceptor blocking agents such as atenolol, metoprolol, and timolol (10 mumol/l each), however, did not share this effect. Moreover, both stereoisomers of propranolol were equipotent in suppression of ischemia-induced noradrenaline release, indicating a property of propranolol independent from interaction with beta-adrenoceptors. The well known local anesthetic action of propranolol was not likely to cause its inhibitory effect on ischemia-induced noradrenaline release, as lidocaine (10 mumol/l) did not affect noradrenaline overflow in ischemia. The effect of propranolol was further examined in cyanide intoxication, an experimental model of energy depletion. In this experimental setting the release of dihydroxyphenylethyleneglycol--the major neuronal metabolite of noradrenaline--served as indicator of increased axoplasmic noradrenaline levels which are present during nonexocytotic noradrenaline release. In cyanide intoxication DL-propranolol also reduced noradrenaline overflow but did not affect release of dihydroxyphenylethylene glycol. The latter finding suggests an interaction of propranolol with the neuronal membrane transport of noradrenaline. In ischemia and cyanide intoxication, transport of noradrenaline across the plasma membrane is known to be driven by the noradrenaline carrier (uptake1) working in reverse of its normal direction--from inside to outside. Consequently, inhibitors of the noradrenaline carrier like desipramine were shown to suppress nonexocytotic noradrenaline release in ischemia and cyanide intoxication.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2314483     DOI: 10.1007/bf00195057

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  34 in total

1.  [THE EFFECT OF DRUGS ON THE ELIMINATION OF NORADRENALIN FROM PERFUSION FLUID AND NORADRENALIN UPTAKE IN THE ISOLATED HEART].

Authors:  R LINDMAR; E MUSCHOLL
Journal:  Naunyn Schmiedebergs Arch Exp Pathol Pharmakol       Date:  1964-07-28

2.  Possible role of a beta-adrenoceptor in the regulation of noradrenaline release by nerve stimulation through a positive feed-back mechanism.

Authors:  E Adler-Graschinsky; S Z Langer
Journal:  Br J Pharmacol       Date:  1975-01       Impact factor: 8.739

3.  Release of noradrenaline in myocardial ischemia--importance of local inactivation by neuronal and extraneuronal mechanisms.

Authors:  L Carlsson; T Abrahamsson; O Almgren
Journal:  J Cardiovasc Pharmacol       Date:  1986 May-Jun       Impact factor: 3.105

Review 4.  Autonomic neural influences on the dysrhythmias resulting from myocardial infarction.

Authors:  P B Corr; R A Gillis
Journal:  Circ Res       Date:  1978-07       Impact factor: 17.367

5.  Saturation of monoamine oxidase by intraneuronal noradrenaline accumulation.

Authors:  F J Stefano; U Trendelenburg
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1984-12       Impact factor: 3.000

Review 6.  Modulation of neurotransmission by purine nucleotides and nucleosides.

Authors:  B B Fredholm; P Hedqvist
Journal:  Biochem Pharmacol       Date:  1980-06-15       Impact factor: 5.858

7.  Calcium-dependence of catecholamine release from bovine adrenal medullary cells after exposure to intense electric fields.

Authors:  D E Knight; P F Baker
Journal:  J Membr Biol       Date:  1982       Impact factor: 1.843

8.  Adenosine inhibits exocytotic release of endogenous noradrenaline in rat heart: a protective mechanism in early myocardial ischemia.

Authors:  G Richardt; W Waas; R Kranzhöfer; E Mayer; A Schömig
Journal:  Circ Res       Date:  1987-07       Impact factor: 17.367

9.  Inhibition of synaptosomal [3H]noradrenaline uptake by beta-adrenoceptor blocking drugs: influence of lipophilicity.

Authors:  J A Street; A Walsh
Journal:  Eur J Pharmacol       Date:  1984-07-13       Impact factor: 4.432

10.  The effects of some beta-adrenoreceptor blocking drugs on the uptake and release of noradrenaline by the heart.

Authors:  J W Foo; A Jowett; A Stafford
Journal:  Br J Pharmacol       Date:  1968-09       Impact factor: 8.739

View more
  5 in total

1.  Nonexocytotic noradrenaline release and ventricular fibrillation in ischemic rat hearts.

Authors:  T Kurz; B Offner; J Schreieck; G Richardt; R Tölg; A Schömig
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1995-11       Impact factor: 3.000

2.  Cardiotoxicity of adrenochrome in isolated rabbit hearts assessed by epicardial NADH fluorescence.

Authors:  A F Rump; W Klaus
Journal:  Arch Toxicol       Date:  1994       Impact factor: 5.153

3.  Evidence for norepinephrine cardiotoxicity mediated by superoxide anion radicals in isolated rabbit hearts.

Authors:  A F Rump; W Klaus
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1994-03       Impact factor: 3.000

4.  Propranolol unmasks class III like electrophysiological properties of norepinephrine.

Authors:  S Dhein; R Gerwin; U Ziskoven; M Schott; A F Rump; Y Zhao; A Salameh; W Klaus
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1993-12       Impact factor: 3.000

5.  Role of angiotensin and sodium intake in cardiac noradrenaline release.

Authors:  G Richardt; E Mayer; A Schömig
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1991-09       Impact factor: 3.000

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.